Manufacturing & Bioprocessing - software & AI news

Daily news on software, AI, and companies shaping manufacturing & bioprocessing.

Showing 98 results
Press release cover image

Oct 7, 2026

Multiply Labs Raises $75 Million Series B to Close the Gap Between Drug Discovery and Drug Manufacturing

Series B funding will strengthen Multiply Labs' momentum scaling the robotic manufacturing platform turning AI-discovered drugs into treatments patients can receive.SAN FRANCISCO--(BUSINESS WIRE)--Multiply Labs, the physical AI company automating some of the most complex manufacturing processes in medicine, today announced a $75 million Series B, bringing its total capital raised to over $100 million since its founding in 2016. The round was led by Dr. Patrick Soon-Shiong with NantWorks, with ne
Press release cover image

Oct 6, 2026

API Innovation Center Launches the U.S.’ First Benchmark for Pharmaceutical Supply Chain Fragility

ST. LOUIS, Oct. 06, 2026 (GLOBE NEWSWIRE) -- More than 550 million prescriptions in 2023 were filled for medicines with High or Severe supply-chain fragility, according to new analysis released today by the API Innovation Center (APIIC). The findings come from APIIC’s National Fragility Index (NFI), the first benchmark designed to measure and track structural fragility across U.S. pharmaceutical supply chains. Introduced at an October 6th event for policymakers and industry leaders, the NFI pr
Press release cover image

Oct 6, 2026

Biopharma's Leapfrog Moment: The Launch of the Digital CMC Consortium

Uniting industry leaders to build the digital standards and infrastructure needed for the future of drug developmentDOVER, Del., Oct. 6, 2026 /PRNewswire/ -- The Digital CMC Consortium today launched as a new industry collaboration uniting biopharmaceutical organizations, biotech firms, CDMOs, technology providers, and consulting experts around a singular goal: the end-to-end digitalization of Chemistry, Manufacturing, and Controls (CMC).Established with participation from leaders at Novartis, T
Press release cover image

Oct 6, 2026

Thermo Fisher Scientific Showcases New Solutions and Expanded Capabilities to Accelerate Drug Development at CPHI Milan 2026

New development solutions, expanded global capacity, and advanced digital technologies help pharma and biotech companies reduce complexity and scale toward commercializationKey factsNew solutions for drug product development: New OSD Express and Steriles Express Solutions provide defined development approaches designed to increase predictability and help programs advance more efficiently, while Accelerator™ Drug Development connects capabilities across development to reduce handoffs and maintain
Press release cover image

Oct 6, 2026

RoslinCT Awarded £7.25 million Scottish Enterprise R&D Grant to Advance Digital Cell Therapy Manufacturing

EDINBURGH, Scotland--(BUSINESS WIRE)--RoslinCT, a leading global cell therapy Contract Development and Manufacturing Organization (CDMO), today announced it has been awarded a Research & Development grant from Scottish Enterprise to accelerate the digital transformation of its manufacturing operations in Scotland.The funding, supported by a Scottish Enterprise R&D grant of up to £7.25 million, forms part of RoslinCT's ambitious digital expansion plan, a multi-year initiative designed to
A flat design of a syringe representing mRNA vaccine delivery.

Oct 5, 2026

How AI is transforming biopharma manufacturing facilities of the future

Artificial intelligence is revolutionizing the biopharmaceutical landscape, significantly accelerating the journey from drug development to patient delivery.AI technologies are enabling researchers to swiftly identify viable drug candidates and analyze extensive biological data, reducing the time traditionally required for laboratory research and validation from years to mere months. This rapid advancement has resulted in pharmaceutical companies advancing more therapies through the development
Press release cover image

Sep 28, 2026

Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA

REDWOOD CITY, Calif., Sept. 28, 2026 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced an agreement with a pioneering siRNA drug innovator to explore stereo-defined fragment synthesis using its ECO Synthesis® Manufacturing Platform. The agreement builds on advances presented at TIDES USA 2026, where for the first time, Codexis demonstrated full-length siRNA synthesis with precise con
A minimalist representation of a gear symbolizing process intensification in manufacturing.

Sep 23, 2026

Digital Shadows to Aid Complexity in Handling Process Intensification

Recent insights from biotechnology expert William Whitford highlight the potential of in silico AI-augmented models, termed digital shadows, to facilitate process intensification in manufacturing without the regulatory complexities associated with active control systems.Whitford, the founder of Oamaru BioSystems, differentiates digital shadows from digital twins. While both serve as real-time digital representations of processes or equipment, digital shadows focus solely on reporting rather than
A bioreactor with CHO cells in a biomanufacturing facility

Sep 23, 2026

Multi-Controller System: Major Boost to Continuous CHO Perfusion

Researchers at Sartorius have developed a nonlinear model predictive control (NMPC) system that significantly enhances the productivity of continuous biomanufacturing for Chinese hamster ovary (CHO) cells, achieving a 68% increase in production while maintaining viable cell density above 95%.This innovative NMPC system allows biomanufacturers to effectively manage feed, bleed, and harvest flows, facilitating a seamless shift between operational stability and economic optimization. According to S
Press release cover image

Sep 23, 2026

L7 20Informatics 20Makes 20the 20Case 20for 20CMC-in-the-Loop 20- 20BioSpace 20Press 20Release

AsAI-driven discovery floods the pipeline with candidates, L7 Informatics arguesthe constraint on speed to patients has moved from the lab to Chemistry,Manufacturing, and Controls, and that orchestrating the work across internallabs and external partners on one governed data model is how precision sciencescales.AUSTIN,Texas, September 22, 2026 — Artificial intelligence is accelerating drugdiscovery faster than the systems meant to turn candidates into medicines canabsorb. According to L7 Informa
A hematopoietic stem cell in a test tube on a lab bench, with scientific equipment in the background.

Sep 23, 2026

Cellares pens 2nd automation test with Asia-based cell therapy partner in 2 weeks

Cellares has secured its second partnership with an Asia-based organization in just over a week, marking a significant step in its automated cell therapy manufacturing efforts. This latest collaboration is with Seoul National University Hospital (SNUH) in South Korea, where the focus will be on evaluating the integration of SNUH’s gene-modified hematopoietic stem and progenitor cell manufacturing process into Cellares' Cell Shuttle platform.The partnership aims to test an investigational cell th
Press release cover image

Sep 21, 2026

Andelyn and Its Curator® Platform Achieve First FDA-Approved Commercial Gene Therapy Manufacturing Milestone Following FDA Approval of Ultragenyx's FAYUVI™ to Treat Sanfilippo Syndrome Type A (MPS IIIA)

COLUMBUS, Ohio, Sept. 18, 2026 /PRNewswire/ -- Andelyn Biosciences ("Andelyn"), a leading, patient-focused cell and gene therapy Contract Development and Manufacturing Organization ("CDMO"), today announced it is now manufacturing FAYUVI™ (rebisufligene etisparvovec-hopf), an FDA-approved gene therapy, for commercial supply at its Columbus, Ohio facility. The announcement follows the U.S. Food and Drug Administration's approval of Ultragenyx Pharmaceutical Inc.'s FAYUVI™ for treating Sanfilippo